Disulfiram as an anti-inflammatory agent: mechanisms, nano-delivery strategies, and applications in non-oncologic diseases
Qiwen Jiang, Mengni Jiang, Yanwei Lv, Xinyuan Zhang, Shige Wang, Jiulong Zhao
Abstract
, hepatitis and colitis). While challenges remain in clinical translation, integrating DSF with nanotechnology offers a transformative approach to harnessing its anti-inflammatory properties. This review highlights current advancements, unresolved questions, and future directions for optimizing DSF-based therapies in inflammation management.
Topics & Concepts
MedicineDisulfiramDrugInflammationPharmacologyPEGylationHepatitisCoronavirus disease 2019 (COVID-19)Systemic lupus erythematosusAutoimmune hepatitisMacrophageTransformative learningAutophagyLiver injurySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug discoveryNanomedicineTargeted drug deliverySafety profileImmune systemHeme Oxygenase-1 and Carbon MonoxideAlcohol Consumption and Health EffectsInflammasome and immune disorders